Evidence map›Paper›PMID 25165483›Full record

ArticleAIDS research and therapy2014

Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.

Alain Lafeuillade, Mark Wainberg, Marie-Lise Gougeon, Sabine Kinloch-de Loes, Philippe Halfon, Hervé Tissot-Dupont

Abstract read
In one paragraph

Article in AIDS research and therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alain LafeuilladeDepartment of Infectious Diseases, General Hospital, Toulon, France.
Mark WainbergMcGill University, Montreal, Canada.
Marie-Lise GougeonAntiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Pasteur Institute, Paris, France.
Sabine Kinloch-de LoesRoyal Free Center for HIV Medicine, Department of Infection and Immunity, Royal Free Hospital, London, UK.
Philippe HalfonInternal Medicine and Infectious Diseases Department, European Hospital and Alphabio Laboratory, Marseille, France.
Hervé Tissot-DupontHealth Department, Research Institute for Development, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2014 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis and transformed this infection into a chronic disease. However, HIV is able to persist within the infected host and the pandemic is still growing. The main 2014 ISHEID theme was, hence "Together for a world without HIV and AIDS". In this report we not only give details on this main topic but also summarize what has been discussed in the areas of HCV coinfection and present a short summary on currently emerging viral diseases.

Indexed as

Antiretroviral drugsHCVHepatitis EHIVHIV cureHIV reservoirsHIV vaccine

Identifiers

PMID25165483
PMCPMC4145833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.